Anticancer

Inulanolide A
Catalog No: CFN92801

Inulanolide A is a novel NFAT1 and MDM2 dual targeting agent and may be a clinical candidate for breast cancer therapy. Inulanolide A has potent cytotoxicity.

14-Deoxyandrographolide
Catalog No: CFN92802

14-Deoxyandrographolide has hepatoprotective activity, mediates activation of adenylate cyclase-cAMP signaling leading to up-regulation of cNOS, may provide a promising approach in the prevention of liver diseases during chronic alcoholism. It desensitizes hepatocytes to TNF-alpha-mediated apoptosis through the release of TNFRSF1A.

Ginsenoside Rs3
Catalog No: CFN92813

Ginsenoside Rs3 induce apoptosis, is related to the elevations of p53 and p21WAF1 in the cells.

Gamma-Tocotrienol
Catalog No: CFN92817

Gamma-Tocotrienol has antioxidant activity, it as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets. Gamma-Tocotrienol is a novel blocker of the STAT3 activation pathway, it can induce the apoptosis on human gastric cancer SGC-7901 cells via mitochondria-dependent apoptosis pathway, with a potential role in future therapies for HCC and other cancers.

Ginsenoside Rk2
Catalog No: CFN92818

Ginsenoside Rk1 has anti-tumor, and anti-platelet aggregation activities. Ginsenoside Rk1 can strongly inhibit permeability induced by VEGF, advance glycation end-product, thrombin, or histamine in human retinal endothelial cells, it reduces the vessel leakiness of retina in a diabetic mouse model; this anti-permeability activity of Rk1 is correlated with enhanced stability and positioning of tight junction proteins at the boundary between cells; Rk1 induces phosphorylation of myosin light chain and cortactin, which are critical regulators for the formation of the cortical actin ring structure and endothelial barrier.